Peptide Hormone Synthesis and Diagnostic Relevance

Peptide Hormones: Abundance and Structure

  • Peptide hormones are the most abundant type of hormones and are produced in practically all endocrine glands, with the exception of the adrenal gland.

  • They are proteins, i.e., strings of amino acids connected by peptide bonds.

  • Amino acid length varies by hormone: from as short as 3 amino acids up to 200 amino acids. Example ranges:

    • Thyrotropin releasing hormone (TRH): relatively short

    • Glucagon: longer string of amino acids

  • Some peptide hormones form structural elements like alpha helices (e.g., glucagon and insulin).

  • Many peptide hormones are glycosylated, forming glycoproteins (protein + sugar moieties).

  • Glycosylation can:

    • Improve hormone half-life, and

    • Alter receptor interaction by changing the hormone’s shape and how it fits the ligand-binding site on target cells.

Synthesis Pathway for Peptide Hormones

  • Since peptide hormones are proteins, their synthesis follows the same cellular gene-to-protein flow as other proteins:

    • DNA in the nucleus is transcribed into messenger RNA (mRNA).

    • mRNA is translated by ribosomes to produce a protein.

  • Peptide hormones start as longer precursors before becoming active forms:

    • The initial product is a preprohormone (or prepropeptide).

    • “Pre” and “pro” both mean “before”; thus the preprohormone is the “before before hormone.”

  • Final biologically active peptide is obtained after sequential cleavages that trim the precursor into the active form.

Key Processing Steps: From Preprohormone to Active Hormone

  • Step 1: Transcription/Translation

    • Translation begins in the rough endoplasmic reticulum (RER) to form the preprohormone.

  • Step 2: Signal peptide directs trafficking

    • A signal peptide (a sequence of amino acids) directs the preprohormone to the lumen of the rough ER.

    • The signal peptide is cleaved during processing, yielding the prohormone (or propeptide).

    • This represents the conversion: extpreprohormone<br>ightarrowextprohormoneext{preprohormone} <br>ightarrow ext{prohormone} after signal peptide removal.

  • Step 3: Transport to Golgi and post-translational modifications

    • The prohormone is packaged into transport vesicles and sent to the Golgi apparatus for further processing.

    • Modifications in the Golgi include post-translational changes (glycosylation, disulfide bond formation, etc.).

  • Step 4: Secretory vesicle packaging and final cleavages

    • Processed prohormones are packaged into secretory vesicles.

    • Additional cleavages remove inactive fragments of the prohormone to yield the final physiologically active hormone.

    • The mature hormone is stored in secretory vesicles until a signal triggers exocytosis.

  • Summary overview (conceptual path):

    • extpreprohormone<br>ightarrowextprohormone<br>ightarrowextactivepeptideext{preprohormone} <br>ightarrow ext{prohormone} <br>ightarrow ext{active peptide}

Storage and Secretion: Why Secretory Vesicles?

  • Peptide hormones are lipophobic (hydrophilic).

  • Hydrophilic hormones do not diffuse through lipid membranes.

  • Therefore, they are stored in secretory vesicles within cells and released by exocytosis when signaled.

  • If peptide hormones were lipophilic (hydrophobic), they could diffuse out of vesicles and membranes, making storage impractical.

Post-Translational Modifications and Variants

  • Post-translational modifications can include:

    • Glycosylation (attachment of sugar groups)

    • Formation of disulfide bonds

    • Other modifications not detailed here

  • Some prohormones yield a single active hormone after processing; others can yield multiple hormones from a single prohormone.

Multiple Hormones from a Single Prohormone

  • Example where a single prohormone yields several hormones after processing:

    • Proopiomelanocortin (POMC) can be cleaved to generate three different hormones:

    • ACTH (adrenocorticotropic hormone)

    • γ-lipotropin

    • β-endorphin

    • Pronounced example noted for emphasis later in the course: POMC-derived hormones.

  • In contrast, some hormones come directly from their prohormone with no extra active fragments.

Insulin: A Detailed Prohormone Example

  • Insulin is produced from an insulin preprohormone with a signal sequence guiding entry into the rough ER.

  • Processing yields not only insulin but also an inactive fragment called the C peptide.

    • The C peptide is released in equimolar amounts with insulin during exocytosis: for every molecule of insulin, one molecule of C peptide is released.

  • Clinical relevance of C peptide:

    • C peptide has a longer half-life in blood than insulin and is easier to measure.

    • C peptide levels can be used to assess endogenous insulin production via assays such as ELISA.

    • This is important in evaluating conditions like diabetes and hypoglycemia.

Clinical Context: C-Peptide and Diabetes

  • C peptide measurement helps distinguish between Type 1 and Type 2 diabetes:

    • Type 1 diabetes: autoimmune destruction of pancreatic beta cells; reduced insulin and C peptide production.

    • Type 2 diabetes: insulin resistance with relative insulin deficiency over time; endogenous insulin and C peptide may be preserved early on.

  • A typical teaching example uses an assay to measure circulating hormone levels and interprets results in the context of diabetes type.

Diagnostic Techniques: RIA vs ELISA (Illustrative Review)

  • Quick review concept from a standard curve example:

    • If a dish (sample) shows 100% binding of radioactive hormone, with no cold (non-radioactive) hormone competing, this suggests very low endogenous hormone production in that sample (as in Type 1 diabetes).

    • Detection method in the example is Radioimmunoassay (RIA): uses radioactive hormone for detection/binding.

    • In contrast, ELISA uses antibodies and non-radioactive detection to quantify the hormone or its fragments (e.g., C peptide).

  • Interpretation context:

    • Type 1 diabetes: autoimmune destruction → low insulin and low C peptide → high binding in a radioactive assay due to lack of competing cold hormone.

    • Type 2 diabetes: insulin resistance; endogenous insulin and C peptide may be higher than in Type 1.

  • The example emphasizes how C peptide testing (and its choice of assay) can inform about endogenous insulin production and diabetes type.

Notable Examples and Terms Mentioned

  • Examples of peptide hormones with distinct features:

    • TRH: relatively short amino acid sequence.

    • Glucagon: longer peptide; forms alpha helices; subject to glycosylation in some cases.

    • PTH (parathyroid hormone) and calcitonin: examples where the final hormone is produced after removing the inactive fragments.

  • Significance of glycosylation and disulfide bonds in peptide hormones:

    • They can modulate stability, half-life, and receptor binding affinity.

  • Insulin and C peptide:

    • Equal stoichiometric release during exocytosis.

    • C peptide is a clinically useful surrogate for endogenous insulin secretion.

Connections to Foundational Principles and Real-World Relevance

  • Central dogma alignment: DNA -> mRNA -> protein (peptide hormone) and subsequent post-translational processing.

  • Structure-function relationship: amino acid length, helices, and post-translational modifications influence receptor binding and activity.

  • Pharmacodynamics and pharmacokinetics relevance: half-life alterations via glycosylation; storage in vesicles; rapid exocytosis in response to stimuli.

  • Clinical diagnostics: C peptide as a diagnostic and monitoring tool for insulin production; distinction between Type 1 and Type 2 diabetes informs treatment choices.

  • Laboratory techniques: understanding RIA vs ELISA is essential for interpreting diagnostic data and inferring endogenous hormone production.

Formulas and Key Equations (LaTeX)

  • Preprohormone processing chain:

    • extpreprohormone<br>ightarrowextprohormone<br>ightarrowextactivepeptideext{preprohormone} <br>ightarrow ext{prohormone} <br>ightarrow ext{active peptide}

  • POMC cleavage example:

    • ext{POMC}
      ightarrow ext{ACTH} + ext{γ-LPH} + eta ext{-endorphin}

  • Insulin biosynthesis (conceptual):

    • extpreproinsulin<br>ightarrowextproinsulin<br>ightarrowextinsulin+extC−peptideext{preproinsulin} <br>ightarrow ext{proinsulin} <br>ightarrow ext{insulin} + ext{C-peptide}

  • Signal peptide function (conceptual):

    • The signal peptide directs the nascent peptide to the lumen of the rough endoplasmic reticulum (RER) for processing, after which the signal peptide is cleaved.

Quick Takeaways for Exam Prep

  • Peptide hormones are produced in nearly all glands (except the adrenal gland in the given context) and range from very short to quite long amino acid chains.

  • Glycosylation and other post-translational modifications influence stability and receptor interactions.

  • The preprohormone → prohormone → active hormone pathway explains why peptides are stored in secretory vesicles and released by exocytosis.

  • Some prohormones yield multiple hormones; others yield a single final hormone.

  • Insulin production yields C-peptide, which is useful clinically to assess endogenous insulin production.

  • RIA vs ELISA differ in detection approach; C-peptide measurement via ELISA is commonly used to gauge insulin secretion, aiding in distinguishing Type 1 vs Type 2 diabetes.